Sydney-based SimConverse has collected A$1.5 million (around $987,000) in a seed funding round led by Folklore Ventures, with participation from Artesian.
WHAT IT DOES
Founded in 2020, SimConverse is a simulation platform that uses generative AI to play the role of any patient, colleague or casualty for healthcare communications training. It is made to be adaptable and customisable to suit the...
Sixty percent of respondents said they would feel uncomfortable if their healthcare provider relied on AI to diagnose and treat them, according to a survey conducted by the Pew Research Center.
The 2022 survey, which included responses from more than 11,000 U.S. adults, found that 66% of women said they would feel uncomfortable if their provider relied on AI for their medical care, while 54% of...
Vietnamese healthcare AI developer VinBrain has started a new partnership with Stanford University to enhance AI medical imaging.
Based on their latest data use agreement, Stanford will initially provide VinBrain access to about 240,000 anonymised medical images and reports to train and test the AI on its DrAid clinical decision support platform while also helping improve the accuracy of an...
Indian biotech company Mylab Discovery Solutions is integrating Qure.ai's AI technology into its upcoming x-ray device for screening tuberculosis.
According to a press statement, MyBeam is a compact, lightweight device equipped with high-frequency technology for detecting TB. It will be powered by Qure.ai's deep-learning software qXR to analyse chest x-ray images and identify TB within a minute...
Researchers from the Commonwealth Scientific and Industrial Research Organisation, in partnership with the Queensland University of Technology, have developed what could be the world's first AI-based benchmark for measuring brain atrophy.
WHAT IT'S ABOUT
They used AI to develop a set of artificial MRI brain images with predefined signs of neurodegeneration in the cortex region, an area of the...
NERVTEX, a Chinese company focused on developing digital therapeutics for brain disorders, has obtained the approval of the China National Medical Products Administration for its AI-powered movement disorder analysis software.
Called MoDAS (Movement Dysfunction Assessment Software), the software as a medical device uses computer vision and deep learning to analyse videos of a patient's movement...
South Korean AI company Lunit has tied up with its investor, Guardant Health, for AI integration.
Under the partnership, Lunit will integrate its PD-L1 scoring algorithm into Guardant's cancer biomarker detection workflow in the Guardant360 TissueNextTM PD-L1 test for non-small cell lung cancer (NSCLC).
Lunit SCOPE PD-L1, a CE-marked AI solution, detects and analyses PD-L1, a type of cancer...
Hong Kong-based health tech startup PanopticAI has raised undisclosed seed funding from a round co-led by Alibaba Hong Kong Entrepreneurs Fund and Gobi Partners. The round was also participated by HKUST Entrepreneurship Fund and other investors.
WHAT IT DOES
Founded by researchers from The Hong Kong University of Science and Technology, Panoptic AI develops digital health solutions that provide...
Two Japanese companies, health tech firm Four H and Aculys Pharma, a biopharmaceutical company focused on treating mental health disorders, are collaborating to further understand and help people with sleeping disorders.
Their goal is to have an objective understanding of sleeping disorders, particularly narcolepsy and excessive daytime sleepiness associated with obstructive sleep apnea (OSA)....
Health charity Skin Check Champions, the University of South Australia, and The Hospital Research Foundation have teamed up to launch a pop-up clinic that uses AI to diagnose skin cancer.
Their pop-up clinic is led by nurses who take high-quality lesion images from patients, which are then triaged and conditionally diagnosed by AI algorithms to check if they are cancerous. The results are also...
